Atara Biotherapeutics, Inc. (ATRA)

Nasdaq: ATRA · Biological Products, (No Diagnostic Substances) · Thousand Oaks, CA · filing with the SEC since 2014

Grade3.9

◀ Past 3.9● Present 3.3▶ Future 4.7

Overview Business Financials Grade Forecast Sentiment Ownership People Filings Patents Chart

Income statement, as filed

In thousands of US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in December.

Income statement, by fiscal year, newest first
Fiscal year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Report filed	Mar 16, 2026	Mar 7, 2025	Mar 28, 2024	Feb 8, 2023	Feb 28, 2022	Mar 1, 2021	Feb 27, 2020	Feb 26, 2019	Feb 27, 2018	Mar 9, 2017
Revenue	120,772	128,940	8,573	63,573	·	·	·	·	·	·
For lenders
Interest and dividend income	683	2,110	5,426	3,059	·	·	·	·	·	·
Research and development	37,445	151,483	224,785	272,533	282,001	244,650	216,097	167,457	81,206	56,514
General and administrative	26,253	39,886	50,908	71,553	78,801	64,402	79,584	69,654	40,326	24,728
Total operating expenses	·	·	·	344,086	360,802	309,052	295,681	237,111	121,532	81,242
Total costs and expenses	84,910	212,378	284,579	344,086	·	·	·	·	·	·
Operating income	35,862	-83,438	-276,006	-280,513	-340,462	-309,052	-295,681	-237,111	-121,532	-81,242
Interest expense	3,792	4,615	5,285	373	·	·	·	·	·	·
Other income (expense), net	-34	528	-246	-700^r	367	2,447	4,717	6,368	2,027	2,203
Income before income taxes	32,719	-85,415	-276,111	-228,290	-340,095	-306,605	-290,964	-230,743	-119,505	-79,039
Income tax expense	31	-12	15	12	46	15	12	-44	-14	10
Net income including non-controlling interests	32,688	-85,403	-276,126	-228,302	-340,141	-306,620	-290,976	-230,699	-119,491	-79,049
Net income	32,688	-85,403	-276,126	-228,302	-340,141	-306,620	-290,976	-230,699	-119,491	-79,049
Earnings per share, basic	2.61	-11.41	-65.19^r	-56.00^b	-90.75^b	-103.75^b	·	·	·	·
Earnings per share, diluted	2.57	-11.41	-65.19^r	-56.00^b	-90.75^b	-103.75^b	·	·	·	·
Earnings per share, basic and diluted	·	·	·	·	-90.75^b	-103.75^b	-141.75^b	-131.75^b	-100.00^b	-68.75^b
Weighted average shares, basic	12,544,000	7,488,000	4,236,000^r	4,079,600^b	3,746,800^b	2,958,920^b	·	·	·	·
Weighted average shares, diluted	12,718,000	7,488,000	4,236,000^r	4,079,600^b	3,746,800^b	2,958,920^b	·	·	·	·
Weighted average shares, basic and diluted	·	·	·	·	3,746,800^b	2,958,920^b	2,052,320^b	1,752,440^b	1,194,520^b	1,149,280^b

As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.Share counts and per-share figures are on the newest report's basis, after the 1-for-25 reverse split.A dot is a line not tagged for that period. ^r restated by the company in a later report; ^b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.

What each line is, and the XBRL concept behind it

Revenue what customers paid for what it sold

us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
us-gaap:Revenues

Interest and dividend income what its loans and securities earnedus-gaap:InterestIncomeOperating

Research and development spent on inventing what it sells nextus-gaap:ResearchAndDevelopmentExpense

General and administrative the cost of running the company itselfus-gaap:GeneralAndAdministrativeExpense

Total operating expenses the running costs togetherus-gaap:OperatingExpenses

Total costs and expenses every operating cost, the cost of revenue includedus-gaap:CostsAndExpenses

Operating income profit from running the business, before interest and taxus-gaap:OperatingIncomeLoss

Interest expense what its borrowing costus-gaap:InterestExpense

Other income (expense), net gains and costs outside the businessus-gaap:OtherNonoperatingIncomeExpense

Income before income taxes profit before taxus-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest

Income tax expense tax charged on the period's profitus-gaap:IncomeTaxExpenseBenefit

Net income including non-controlling interests the whole group's profit, minority holders' share includedus-gaap:ProfitLoss

Net income the profit or loss that belongs to the company's shareholdersus-gaap:NetIncomeLoss

Earnings per share, basic net income per share outstandingus-gaap:EarningsPerShareBasic

Earnings per share, diluted net income per share, counting every share that could be issuedus-gaap:EarningsPerShareDiluted

Earnings per share, basic and diluted net income per share, where both counts are the sameus-gaap:EarningsPerShareBasicAndDiluted

Weighted average shares, basic the average count of shares outstandingus-gaap:WeightedAverageNumberOfSharesOutstandingBasic

Weighted average shares, diluted the average count with every share that could be issuedus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Weighted average shares, basic and diluted the average count, where both counts are the sameus-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted

SI Assistanton ATRA · research, not advice